In the analysis comparing the upper three quartiles (Q2-4) to the bottom quartile (Q1) of the biomarkers (Table 3), a higher level of TC (HR 0.92; 95% CI 0.87–0.98), LDL-C (HR 0.86; 95% CI 0.79–0.93), HDL-C (HR 0.90; 95% CI 0.83–0.96), TG (HR 0.94; 95% CI 0.88–0.99), and ApoA-I (HR 0.88; 95% CI 0.82–0.95) was associated with a lower risk of any hematological malignancy. Here, APOA1 is linked to hematologic disorder.